These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

893 related items for PubMed ID: 22481443

  • 1. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E, Beglinger C.
    Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
    [Abstract] [Full Text] [Related]

  • 2. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 3. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 4. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 5. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.
    Zhulina Y, Cao Y, Amcoff K, Carlson M, Tysk C, Halfvarson J.
    Aliment Pharmacol Ther; 2016 Sep; 44(5):495-504. PubMed ID: 27402063
    [Abstract] [Full Text] [Related]

  • 6. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K, Kiszka-Kanowitz M, Nordgaard-Lassen I, Nielsen AM.
    Ugeskr Laeger; 2014 Sep 08; 176(37):. PubMed ID: 25294035
    [Abstract] [Full Text] [Related]

  • 7. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G.
    World J Gastroenterol; 2017 Nov 07; 23(41):7387-7396. PubMed ID: 29151692
    [Abstract] [Full Text] [Related]

  • 8. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan 07; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 9. Faecal calprotectin in the diagnosis of inflammatory bowel disease.
    Burri E, Beglinger C.
    Biochem Med (Zagreb); 2011 Jan 07; 21(3):245-53. PubMed ID: 22420238
    [Abstract] [Full Text] [Related]

  • 10. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.
    Aliment Pharmacol Ther; 2016 May 07; 43(10):1069-79. PubMed ID: 26953251
    [Abstract] [Full Text] [Related]

  • 11. [Faecal calprotectin in inflammatory bowel diseases: review].
    Kallel L, Fekih M, Boubaker J, Filali A.
    Tunis Med; 2011 May 07; 89(5):425-9. PubMed ID: 21557177
    [Abstract] [Full Text] [Related]

  • 12. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 07; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 13. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
    Saha A, Tighe MP, Batra A.
    Arch Dis Child Educ Pract Ed; 2016 Jun 07; 101(3):124-8. PubMed ID: 26848103
    [Abstract] [Full Text] [Related]

  • 14. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S, Shajib MS, Reinisch W, Khan WI.
    J Gastroenterol; 2016 May 07; 51(5):434-46. PubMed ID: 26897740
    [Abstract] [Full Text] [Related]

  • 15. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T, Kolho KL.
    Scand J Gastroenterol; 2010 Aug 07; 45(7-8):872-7. PubMed ID: 20377469
    [Abstract] [Full Text] [Related]

  • 16. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.
    J Gastrointestin Liver Dis; 2014 Sep 07; 23(3):273-8. PubMed ID: 25267955
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.
    Ned Tijdschr Geneeskd; 2003 Nov 29; 147(48):2360-5. PubMed ID: 14677476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB, Longlands MG, Wiener K, Shreeve DR.
    Eur J Gastroenterol Hepatol; 2002 Aug 29; 14(8):841-5. PubMed ID: 12172403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.